March 27, 2023IR
News
March 10, 2023IR
Notice Regarding Dividend Received from a Consolidated Subsidiary[Teijin] (PDF: 71.7 KB)
February 8, 2023CorporateIR
The Teijin Group Reforms for Profitability Improvement[Teijin] (PDF: 1.5 MB)
February 8, 2023IR
Consolidated Financial Statements Summary (For the nine months ended December 31, 2022)[Teijin]
February 8, 2023IR
Flash Report -Results of FY2022 3Q & Outlook for FY2022-[Teijin]
February 8, 2023IR
Notice Regarding the Revision of Financial Forecasts and the Recording of Extraordinary Losses in Consolidated and Non-consolidated Accounts[Teijin] (PDF: 97.4 KB)
February 3, 2023IR
Notice Regarding Change in Representative Directors[Teijin] (PDF: 131.6 KB)
November 7, 2022IR
Consolidated Financial Statements Summary (For the six months ended September 30, 2022)[Teijin]
November 7, 2022IR
Flash Report -Results of FY2022 2Q & Outlook for FY2022-[Teijin]
November 7, 2022IR
Notice Regarding the Revision of Financial Forecasts and the Dividend Forecast[Teijin] (PDF: 116.6 KB)
October 3, 2022IR
Teijin posts Integrated Report 2022[Teijin]
August 8, 2022IR
Consolidated Financial Statements Summary (For the three months ended June 30, 2022)[Teijin]
August 8, 2022IR
Flash Report -Results of FY2022 1Q & Outlook for FY2022-[Teijin]
July 20, 2022IR
Notice Concerning Completion of Payment for the Disposal of Treasury Shares as “Restricted Stock”[Teijin] (PDF: 122.6 KB)
June 22, 2022IR
Notice Concerning the Disposal of Treasury Shares as “Restricted Stock”[Teijin] (PDF: 139.9 KB)
May 12, 2022IR
Consolidated Financial Statements Summary (For the year ended March 31, 2022)[Teijin]
May 12, 2022IR
Flash Report -Results of FY2021 & Outlook for FY2022-[Teijin]
April 28, 2022IR
Notice Regarding the Recording of Extraordinary Income in Non-consolidated Accounts[Teijin] (PDF: 72.2 KB)
March 25, 2022IR
Teijin Held ESG Briefing Session[Teijin]
February 7, 2022IR
Consolidated Financial Statements Summary (For the nine months ended December 31, 2021)[Teijin]
February 7, 2022IR
Flash Report -Results of FY2021 3Q & Outlook for FY2021-[Teijin]
December 27, 2021IR
Teijin Held Regenerative Medicine Business Presentation[Teijin]
December 23, 2021IR
Notice Regarding Change in Representative Directors[Teijin] (PDF: 278.6 KB)
November 30, 2021IR
Notice of Application for Selection of Prime Market in Tokyo Stock Exchange New Market Segments[Teijin] (PDF: 108.1 KB)
November 8, 2021IR
Consolidated Financial Statements Summary (For the six months ended September 30, 2021)[Teijin]
November 8, 2021IR
Flash Report -Results of FY2021 2Q & Outlook for FY2021-[Teijin]
November 8, 2021IR
Notice Regarding Dividends from Surplus (Interim Dividends)[Teijin] (PDF: 82.8 KB)
November 8, 2021IR
Notice Regarding Adjustment of Conversion Price for Zero Coupon Convertible Bonds due 2021[Teijin] (PDF: 143.2 KB)
September 22, 2021IR
Notice Regarding Change of Trade Names of Overseas Consolidated Subsidiaries[Teijin] (PDF: 77.3 KB)
September 15, 2021IR
Teijin posts Integrated Report 2021[Teijin]
August 6, 2021IR
Consolidated Financial Statements Summary (For the three months ended June 30, 2021)[Teijin]
August 6, 2021IR
Flash Report -Results of FY2021 1Q & Outlook for FY2021-[Teijin]
August 4, 2021IR
Notice Concerning Completion of Payment for the Disposal of Treasury Shares as “Restricted Stock”[Teijin] (PDF: 124.8 KB)
July 15, 2021IR
Notice Regarding Pricing of Hybrid Bonds (Subordinated Bonds)[Teijin] (PDF: 93.7 KB)
July 13, 2021IR
Notice Concerning the Disposal of Treasury Shares as “Restricted Stock”[Teijin] (PDF: 132.6 KB)
June 21, 2021IR
Notice Regarding Public Offering of Hybrid Bonds (Subordinated Bonds)[Teijin] (PDF: 91.5 KB)
June 8, 2021IR
Teijin Held Business Overview Presentation[Teijin]
May 11, 2021IR
Notice Regarding Adjustment of Conversion Price for Zero Coupon Convertible Bonds due 2021[Teijin] (PDF: 91.6 KB)
May 11, 2021IR
Notice Concerning Revision of Amount of Remuneration, etc. and Introduction of “Restricted Stock” and “Performance Share Units” as Remuneration Plan for Directors of the Company[Teijin] (PDF: 133.6 KB)
May 11, 2021IR
Consolidated Financial Statements Summary (For the year ended March 31, 2021)[Teijin]
May 11, 2021IR
Flash Report -Results of FY2020 & Outlook for FY2021-[Teijin]
April 28, 2021IR
Notice Regarding the Revision of Financial Forecasts and the Recording of Extraordinary Losses in Consolidated and Non-consolidated Accounts[Teijin] (PDF: 94.4 KB)
April 20, 2021IR
Teijin Held Healthcare Business Field Presentation[Teijin]
April 1, 2021HealthcareIR
Notice Regarding Completion of Transfer of Japan Sales of Type 2 Diabetes Treatments[Teijin] (PDF: 82.4 KB)
March 15, 2021IR
Notice Regarding Determination of the Issue Price for Stock Acquisition Rights as Stock Options[Teijin] (PDF: 140.5 KB)
March 3, 2021IR
Notice Regarding Result of Tender Offer for Shares in Japan Tissue Engineering Co., Ltd. (Stock Code: 7774)[Teijin] (PDF: 155.9 KB)
February 26, 2021HealthcareIR
Notice Regarding Execution of Asset Transfer Agreement for Transfer of Japan Sales, Intellectual Properties, and Manufacturing and Marketing Approval of Type 2 Diabetes Treatments (Nesina®, Liovel®, Inisync®, and Zafatek®)[Teijin] (PDF: 206.4 KB)
February 26, 2021IR
Notice Regarding the Issuance of Stock Acquisition Rights as Stock Options[Teijin] (PDF: 256.6 KB)
February 8, 2021IR
Consolidated Financial Statements Summary (For the nine months ended December 31, 2020)[Teijin]
February 8, 2021IR
Flash Report -Results of FY2020 3Q & Outlook for FY2020-[Teijin]
February 8, 2021IR
Notice Regarding the Revision of Financial Forecasts[Teijin] (PDF: 106.0 KB)
February 3, 2021IR
Notice Regarding Change in Representative Directors[Teijin] (PDF: 148.6 KB)
January 29, 2021IR
Notice Regarding Commencement of Tender Offer for Shares in, and Execution of Capital and Business Alliance Agreement with, Japan Tissue Engineering Co., Ltd. (Stock Code: 7774)[Teijin] (PDF: 204.1 KB)
December 15, 2020IR
Announcement regarding Change of Status of an Equity Method Affiliate to Consolidated Subsidiary[Teijin] (PDF: 201.6 KB)
November 19, 2020IR
Teijin Group Integrated Report 2020 special website released[Teijin]
November 2, 2020IR
Consolidated Financial Statements Summary (For the six months ended September 30, 2020)[Teijin]
November 2, 2020IR
Flash Report -Results of FY2020 2Q & Outlook for FY2020-[Teijin]
November 2, 2020IR
Notice Regarding the Revision of Financial Forecasts[Teijin] (PDF: 70.8 KB)
November 2, 2020IR
Notice Regarding Dividends from Surplus (Interim Dividends) and Year-end Dividend Forecast[Teijin] (PDF: 157.7 KB)
November 2, 2020IR
Notice Regarding Adjustment of Conversion Price for Zero Coupon Convertible Bonds due 2021[Teijin] (PDF: 143.4 KB)
October 15, 2020IR
Teijin Held Materials Business Field Presentation[Teijin]
September 24, 2020IR
Teijin posts Integrated Report 2020[Teijin]
August 5, 2020IR
Consolidated Financial Statements Summary (For the three months ended June 30, 2020)[Teijin]
August 5, 2020IR
Flash Report -Results of FY2020 1Q & Outlook for FY2020-[Teijin]
August 5, 2020IR
Notice Regarding the Revision of Financial Forecasts[Teijin] (PDF: 79.1 KB)
August 5, 2020IR
(Notice) Regarding partial revisions of business results presentation materials for past fiscal years[Teijin] (PDF: 592.6 KB)
May 8, 2020IR
Consolidated Financial Statements Summary (For the year ended March 31, 2020)[Teijin]
May 8, 2020IR
Flash Report -Results of FY2019 & Outlook for FY2020-[Teijin]
May 8, 2020IR
Notice Regarding Adjustment of Conversion Price for Zero Coupon Convertible Bonds due 2021[Teijin] (PDF: 94.1 KB)
March 16, 2020IR
Notice Regarding Determination of the Issue Price for Stock Acquisition Rights as Stock Options[Teijin] (PDF: 142.5 KB)
February 28, 2020IR
Notice Regarding the Issuance of Stock Acquisition Rights as Stock Options[Teijin] (PDF: 252.8 KB)
February 5, 2020IR
Consolidated Financial Statements Summary (For the nine months ended December 31, 2019) [Teijin]
February 5, 2020IR
Flash Report -Results of FY2019 3Q & Outlook for FY2019-[Teijin]
February 5, 2020IR
Medium-Term Management Plan 2020–2022 “ALWAYS EVOLVING”[Teijin]
January 31, 2020IR
Notice Regarding Change in Representative Directors[Teijin] (PDF: 144.7 KB)
November 1, 2019IR
Consolidated Financial Statements Summary (For the six months ended September 30, 2019)[Teijin]
November 1, 2019IR
Flash Report-Results of FY2019 2Q & Outlook for FY2019-[Teijin]
October 31, 2019IR
Notice Regarding Dividends from Surplus (Interim Dividend)[Teijin] (PDF: 116.1 KB)
October 31, 2019IR
Notice Regarding Adjustment of Conversion Price for Zero Coupon Convertible Bonds due 2021[Teijin] (PDF: 107.8 KB)
October 24, 2019IR
Notice Regarding Dividends Received from a Consolidated Subsidiary[Teijin] (PDF: 118.5 KB)
September 27, 2019IR
Teijin posts 2019 Integrated Report[teijin]
August 2, 2019IR
Consolidated Financial Statements Summary (For the three months ended June 30, 2019) [Teijin]
August 2, 2019IR
Flash Report-Results of FY2019 1Q & Outlook for FY2019-[Teijin]
May 22, 2019IR
Notice of Share Transfer Agreement Regarding Sale of our Consolidated Subsidiaries of Film Business (the Transfer of our Consolidated Subsidiaries)[Teijin] (PDF: 276.1 KB)
May 9, 2019IR
Consolidated Financial Statements Summary (For the year ended March 31, 2019) [Teijin]
May 9, 2019IR
Flash Report -Results of FY2018 & Outlook for FY2019-[Teijin]
May 9, 2019IR
Notice Regarding Adjustment of Conversion Price for Zero Coupon Convertible Bonds due 2021[Teijin] (PDF: 108.2 KB)
March 18, 2019IR
Notice Regarding Determination of the Issue Price for Stock Acquisition Rights as Stock Options[Teijin] (PDF: 223.3 KB)
March 8, 2019IR
Notice Regarding Dividends Received from a Consolidated Subsidiary[Teijin] (PDF: 100.6 KB)
March 1, 2019IR
Notice Regarding the Issuance of Stock Acquisition Rights as Stock Options[Teijin] (PDF: 221.0 KB)
February 4, 2019IR
Consolidated Financial Statements Summary (For the nine months ended December 31, 2018) [Teijin] (PDF: 1.0 MB)
February 4, 2019IR
Flash Report -Results of FY2018 3Q & Outlook for FY2018- [Teijin] (PDF: 2.1 MB)
November 5, 2018IR
Consolidated Financial Statements Summary (For the six months ended September 30, 2018) [Teijin]
November 5, 2018IR
Flash Report -Results of FY2018 2Q & Outlook for FY2018-[Teijin]
November 1, 2018IR
Notice of the Resolution of the Board of Directors on the Interim Dividends for 153rd Fiscal Year[Teijin] (PDF: 146.3 KB)
October 30, 2018IR
Teijin posts Integrated Report 2018[Teijin]
September 27, 2018IR
Notice Regarding the Sale of Kyorin Holdings Stock Held by the Company[Teijin] (PDF: 129.4 KB)
September 7, 2018IR
Issuance of Notification on the Extension of the Reexamination Period for the Hyperuricemia and Gout Treatment FEBURIC® (febuxostat)[Teijin] (PDF: 116.2 KB)
August 2, 2018IR
Notice Regarding Completion of the Acquisition of Own Shares and the Result of the Acquisition of Own Shares through ToSTNeT-3[Teijin] (PDF: 202.3 KB)
August 1, 2018IR
Notice Regarding Determination of the Acquisition Price through the Off-Auction Own Share Repurchase Trading System (ToSTNeT-3)[Teijin] (PDF: 115.7 KB)
August 1, 2018IR
Notice Regarding Share Buyback through the Off-Auction Own Share Repurchase Trading System (ToSTNeT-3)[Teijin] (PDF: 90.5 KB)
August 1, 2018IR
Notice Regarding Determination of Matters Relating to the Acquisition of Own Shares[Teijin] (PDF: 86.7 KB)
August 1, 2018IR
Consolidated Financial Statements Summary (For the three months ended June 30, 2018)[Teijin]
August 1, 2018IR
Flash Report – Result of FY2018 1Q & Outlook for FY2018 –[Teijin]
May 9, 2018IR
Notice of the Resolution of the Board of Directors on the Year-end Dividends for 152nd Fiscal Year[Teijin] (PDF: 80.8 KB)
May 9, 2018IR
Notice Regarding Adjustment of Conversion Price for Zero Coupon Convertible Bonds due 2018 and 2021 [Teijin] (PDF: 19.0 KB)
May 9, 2018IR
Notice Regarding the Recording of Extraordinary Losses (Non-consolidated) as a Result of the Absorption-type Merger of a Subsidiary[Teijin] (PDF: 142.0 KB)
May 9, 2018IR
Notice Regarding the Discontinuation (abolition) of the Countermeasures to Large-Scale Acquisitions of Teijin Shares (Takeover Defense Measures)[Teijin] (PDF: 206.4 KB)
May 9, 2018IR
Consolidated Financial Statements Summary (For the year ended March 31, 2018) [Teijin]
May 9, 2018IR
Flash Report - FY2017 Financial Performance & FY2018 Outlook -[Teijin]
March 16, 2018IR
Notice Regarding Determination of the Issue Price for Stock Acquisition Rights as Stock Options[Teijin] (PDF: 144.5 KB)
February 28, 2018IR
Notice Regarding the Issuance of Stock Acquisition Rights as Stock Options to Directors[Teijin] (PDF: 189.7 KB)
February 28, 2018IR
Notice Regarding the Issuance of Stock Acquisition Rights as Stock Options to Employees[Teijin] (PDF: 190.7 KB)
February 5, 2018IR
Consolidated Financial Statements Summary (For the nine months ended December 31, 2017) [Teijin]
February 5, 2018IR